According to a preclinical study from Penn Medicine researchers, a molecular compound mimics the effect of natural chaperones that are depleted in the aging brain.
A “chaperone” molecule that slows the formation of certain proteins reversed disease signs, including memory impairment, in a mouse model of Alzheimer’s disease, according to a study from researchers at the Perelman School of Medicine.
